Abstract
Provided herein are novel phenethylamines as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating depression, drug addiction, alcoholism, post-traumatic stress disorder (PTSD) and neuropathic pain, and processes for preparing such compounds.